Sclerosing perineurioma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:100001D36.1
Who is this for?
Show terms as
16Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Sclerosing perineurioma is a rare, benign peripheral nerve sheath tumor composed of perineurial cells embedded within a densely sclerotic (fibrotic) collagenous stroma. It is classified under the broader category of perineuriomas, which are tumors arising from perineurial cells — the specialized cells that form the perineurium, the protective sheath surrounding peripheral nerve fascicles. Sclerosing perineurioma most commonly presents as a slow-growing, painless, well-circumscribed nodule in the subcutaneous tissue or dermis, with a predilection for the fingers and hands of young adults, although other sites have been reported. The tumor is typically small, usually measuring less than 2 centimeters in diameter. Histologically, sclerosing perineurioma is characterized by whorled or cord-like arrangements of bland spindle-shaped to epithelioid perineurial cells set within abundant hyalinized collagen. The tumor cells characteristically express epithelial membrane antigen (EMA) and claudin-1, which are markers of perineurial differentiation, while being negative for S-100 protein, helping to distinguish this entity from schwannomas and neurofibromas. The tumor is benign with no documented malignant potential, and local recurrence after excision is exceedingly rare. The standard treatment for sclerosing perineurioma is complete surgical excision, which is generally curative. No adjuvant therapy such as chemotherapy or radiation is required. The prognosis is excellent, with the vast majority of patients experiencing no recurrence following adequate removal. Because this is a sporadic tumor with no known hereditary predisposition, genetic counseling is typically not indicated. Patients should be reassured about the benign nature of this lesion.

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Sclerosing perineurioma.

View clinical trials →

No actively recruiting trials found for Sclerosing perineurioma at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Sclerosing perineurioma community →

Specialists

16 foundView all specialists →
LM
Louise A Mawn
Specialist
1 Sclerosing perineurioma publication
CJ
Cassandra Johnson
Specialist
1 Sclerosing perineurioma publication
RS
Reena Singh
AUSTIN, TX
Specialist
1 Sclerosing perineurioma publication
AG
Antonio Gilardi
Specialist
1 Sclerosing perineurioma publication
YV
Yash Vaishnav
DENVER, CO
Specialist
1 Sclerosing perineurioma publication
JB
Julia Berry
Specialist
1 Sclerosing perineurioma publication
AC
Andrea Colizza
Specialist
1 Sclerosing perineurioma publication
RC
Renato Covello
Specialist
1 Sclerosing perineurioma publication
JS
Jonathan Siktberg
NASHVILLE, TN
Specialist
1 Sclerosing perineurioma publication
AG
Antonio Greco
Specialist
1 Sclerosing perineurioma publication
MR
Massimo Ralli
Specialist
1 Sclerosing perineurioma publication
GC
Giulia Coppola
NEW HAVEN, CT
Specialist
1 Sclerosing perineurioma publication
RR
Risa Ross
PORT RICHEY, FL
Specialist
1 Sclerosing perineurioma publication
VV
Vladimir Vincek
GAINESVILLE, FL
Specialist
1 Sclerosing perineurioma publication
BB
Brett Brazen
AVENTURA, FL
Specialist
1 Sclerosing perineurioma publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Sclerosing perineurioma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Sclerosing perineuriomaForum →

No community posts yet. Be the first to share your experience with Sclerosing perineurioma.

Start the conversation →

Latest news about Sclerosing perineurioma

No recent news articles for Sclerosing perineurioma.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Sclerosing perineurioma

What is Sclerosing perineurioma?

Sclerosing perineurioma is a rare, benign peripheral nerve sheath tumor composed of perineurial cells embedded within a densely sclerotic (fibrotic) collagenous stroma. It is classified under the broader category of perineuriomas, which are tumors arising from perineurial cells — the specialized cells that form the perineurium, the protective sheath surrounding peripheral nerve fascicles. Sclerosing perineurioma most commonly presents as a slow-growing, painless, well-circumscribed nodule in the subcutaneous tissue or dermis, with a predilection for the fingers and hands of young adults, altho

How is Sclerosing perineurioma inherited?

Sclerosing perineurioma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Sclerosing perineurioma typically begin?

Typical onset of Sclerosing perineurioma is adult. Age of onset can vary across affected individuals.

Which specialists treat Sclerosing perineurioma?

16 specialists and care centers treating Sclerosing perineurioma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.